13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 28 holding rows worth $482,730,651.
- Accession
- 0001826434-25-000002
- Filer
- CIK 1826434
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 28 entries on the cover page, a total value of $482,730,651 stated on the cover page (in dollars after the unit check, H1), rows summing to $482,730,651 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,423,116 | $53,405,477 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 369,004 | $38,977,893 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 58,258 | $35,828,670 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 202,646 | $32,078,862 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 150,788 | $27,953,079 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 1,121,804 | $24,444,109 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 249,769 | $21,132,955 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 454,201 | $21,093,094 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 1,937,984 | $20,368,212 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 355,366 | $20,099,501 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 161,812 | $19,927,148 | dollars as filed | |
| IDEXX LABS INC COM | 45168D104 | Stock | 44,972 | $18,593,224 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 209,984 | $18,062,824 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 47,472 | $14,648,435 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 347,303 | $14,604,091 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 28,115 | $14,222,254 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 236,407 | $12,657,231 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 388,704 | $12,648,428 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 40,810 | $11,269,273 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 127,567 | $9,804,800 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,472,836 | $8,753,839 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 742,574 | $8,198,017 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 820,793 | $5,712,719 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 144,216 | $5,490,303 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 140,220 | $5,237,217 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 99,700 | $4,617,107 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 37,269 | $2,868,222 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 30,606 | $33,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |